This one appeared in our reports on Friday as we had seen a significant run earlier in the week. No sooner did we congratulate ourselves on riding STXS for that impressive 196% gain from 2.33-6.90, did the stock heat up once again. From the low of 4.15 following Friday’s open, the stock took us on another steady upward climb, this time stairstepping all the way up to a late afternoon high of 8.99 for a intraday gain of 117%
Anyone who happened to catch STXS from the previous low of 2.33 (Tuesday), would have been up 286% on their positions at Friday’s high.
The stock closed at 7.34, holding much of the day’s gains on roughly 25X the 3mo. average volume. With a close like that, we’re on the lookout for a possible continuation of momentum today. Key resistance will be at Friday’s 8.99 swing high.
Inovio Pharmaceuticals, Inc. INO
On Thursday we mentioned that recent interest, INO, had seen a new high on Wednesday, marking a 242% gain from our original alert. This play doesn’t seem to be done yet, this morning gapping up past that previous high of 2.20. At this point INO is beginning to remind us of the Energizer Bunny.
Premier Brands, Inc. BRND
We reminded everyone to keep an eye on BRND in Friday’s morning report, and by the time we released an afternoon update, the stock had already run 53% intraday from .0077 up to .0121. Following that report, the stock continued to ascend, closing at a new high-of-day at .013, extending our total possible gain on the day to 69%
Options Trading Side Notes:
On Tuesday we felt we might see AAPL hit $470 by week’s end. AAPL fell a little short of our projected goal, hitting $462.85 on Friday. However the $455 Calls we were following last week still yielded significant opportunity. At the time of Friday’s afternoon update report, we had observed a run from 2.46 to 4.00. In the last three hours of trading, AAPL broke above $460 and those Calls were trading close to 8.00.
This morning AAPL is trading up to $468, and appears as if it could continue it’s upward trend. If that is indeed the case, we’re going to be shifting our attention to the $460 & $465 Calls.
ARTH, CGEN, SPEX, SANB